Ferric carboxymaltose Completed Phase 4 Trials for Iron Deficiency (ID) / Anemia / Heart Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01922479Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure